This report presents the results of a transparency assessment carried out in Lebanon.
It gives a comprehensive assessment of the level of transparency and the level of
vulnerability to corruption within the six primary functions of the pharmaceutical
sector – registration, inspection, promotion, selection, procurement and distribution
The methodology provides both qualitative and quantitative information. Three
national investigators, selected by the Ministry of Health, collected data by
conducting a series of interviews with 50 carefully selected key informants. The
information collected was then converted using a rough quantification method into a
zero to 10 scale, to provide a score for each function in terms of vulnerability to
corruption (minimal to extreme). The scoring indicates the vulnerability in terms of
the policy, the regulatory and administrative structures and the procedures at the
time of the survey.
The quantitative data reveal that the area of medicine distribution received the
highest score and is minimally vulnerable to corruption; medicines registration,
inspection, and procurement are marginally vulnerable to corruption; and the
promotion and selection functions had the lowest scores and are moderately
vulnerable to corruption.
The results indicate the vulnerabilities of the policy, structures, and procedures in
place at the time of the survey. They do not reveal in any way the level of possible
existing corruption in the country.